On November 14th, the “ChemPharm Annual Summit 2017” was jointly hosted by the China Pharmaceutical Industry Association (CPIA) and the China Association of Pharmaceutical Commerce (CAPC) in Xiamen, Fujian, where the 2017 list of “Top 10 Pharmaceutical Companies in China” was unveiled. This marks the third consecutive year that China Grand Enterprises has made the Top 10. China Grand Enterprises’ subsidiary, Grand Pharmaceutical (China), ranks at number 38 on the 2017 list of “Top 100 Chemical Pharmaceutical Industry Enterprises in China.”

The theme of this year’s summit was “product quality and credibility.” The discussions ranged from topics including those of policy interpretation of relevant industries, pharmaceutical–economic analysis, and the disclosure of pharmaceutical companies’ credibility evaluation scores. This year’s summit is the chemical pharmaceutical industry’s most comprehensive and in-depth authoritative meeting.  The 2017 list unveiled at this year’s summit reflects authoritative, just, and objective views concerning each Chinese pharmaceutical enterprise’s circumstances of production and operation. These top ten enterprises are the core of China’s chemical pharmaceutical industry, representing China’s medical industry elites and further solidifying their roles as the most trusted medical enterprises amongst consumers.

China Grand Pharmaceuticals and Healthcare (CGE Healthcare) has always valued innovation as a key component of their business strategy. CGE Healthcare has continuously brought new products to market through a variety of means such as establishing an independent research and development facility, synthesizing production and research innovation, and international partnerships. These steps have allowed CGE Healthcare to ensure their continuous and stable growth as an enterprise. With decades of experience, CGE Healthcare boasts an integrated R&D, production, and marketing and distribution system alongside a domestic and international market oriented business model. Furthermore, CGE Healthcare has focused on simultaneously developing traditional Chinese medicine, chemical drugs, and biologics.

In response to the fast paced reformation of the Chinese medical system, CGE Healthcare is committed to ensuring the quality of their products above all else. By seeking development through innovation, CGE Healthcare has always considered “serving society” to be their number one priority. CGE Healthcare will strive to endlessly contribute to society through their innovative cooperation with others to establish future products and services.